Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adventrx Pharmaceuticals, Inc.
ADVENTRX Provides Update on Strategic Transaction Process
February 27th, 2009
ADVENTRX Pharmaceuticals, Inc. (NYSE Alternext US: ANX) announced that it has received written indications of interest from numerous companies representing a range of strategic transactions. The Company currently is evaluating all proposals and options. In December 2008, the Company announced that it was exploring a range of strategic options, including the sale or disposition of one or more of its product candidate programs, a strategic business merger and other transactions that maximize the value of the Company's assets. "We are pleased with the number and breadth of opportunities presented to us and are currently negotiating with interested parties," stated Brian M....
Source: Health Business Week (2009-02-27)
|
